Is Krispy Kreme Inc (NASDAQ: DNUT) Proving The Doubters Wrong?

Krispy Kreme Inc (DNUT) concluded trading on Thursday at a closing price of $2.95, with 3.09 million shares of worth about $9.12 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -72.61% during that period and on May 22, 2025 the price saw a loss of about -0.34%. Currently the company’s common shares owned by public are about 170.30M shares, out of which, 85.63M shares are available for trading.

Stock saw a price change of -8.10% in past 5 days and over the past one month there was a price change of -34.15%. Year-to-date (YTD), DNUT shares are showing a performance of -70.29% which decreased to -75.38% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.58 but also hit the highest price of $12.68 during that period. The average intraday trading volume for Krispy Kreme Inc shares is 5.32 million. The stock is currently trading -18.25% below its 20-day simple moving average (SMA20), while that difference is down -31.89% for SMA50 and it goes to -65.91% lower than SMA200.

Krispy Kreme Inc (NASDAQ: DNUT) currently have 170.30M outstanding shares and institutions hold larger chunk of about 56.77% of that.

The stock has a current market capitalization of $503.86M and its 3Y-monthly beta is at 1.35. It has posted earnings per share of -$0.13 in the same period. It has Quick Ratio of 0.28 while making debt-to-equity ratio of 1.31. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for DNUT, volatility over the week remained 2.81% while standing at 8.36% over the month.

Stock’s fiscal year EPS is expected to drop by -203.08% while it is estimated to increase by 117.42% in next year.

Coverage by Morgan Stanley stated Krispy Kreme Inc (DNUT) stock as an Underweight in their note to investors on February 26, 2025, suggesting a price target of $6 for the stock. On November 05, 2024, Morgan Stanley Resumed their recommendations, while on August 27, 2024, Evercore ISI Resumed their ratings for the stock with a price target of $13. Stock get a Buy rating from HSBC Securities on July 23, 2024.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.